The Tehran Eye Study: research design and eye examination protocol by Hassan Hashemi et al.
BioMed CentralBMC Ophthalmology
ssOpen AcceStudy protocol
The Tehran Eye Study: research design and eye examination 
protocol
Hassan Hashemi1,2, Akbar Fotouhi*3,2 and Kazem Mohammad3
Address: 1Farabi Eye Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran, 2Noor Vision Correction Center, Tehran, 
Iran and 3Epidemiology and Biostatistics Department, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
Email: Hassan Hashemi - hhashemi@noorvision.com; Akbar Fotouhi* - afotouhi@sina.tums.ac.ir; 
Kazem Mohammad - mohamadk@sina.tums.ac.ir
* Corresponding author    
Abstract
Background: Visual impairment has a profound impact on society. The majority of visually
impaired people live in developing countries, and since most disorders leading to visual impairment
are preventable or curable, their control is a priority in these countries. Considering the
complicated epidemiology of visual impairment and the wide variety of factors involved, region
specific intervention strategies are required for every community. Therefore, providing
appropriate data is one of the first steps in these communities, as it is in Iran. The objectives of this
study are to describe the prevalence and causes of visual impairment in the population of Tehran
city; the prevalence of refractive errors, lens opacity, ocular hypertension, and color blindness in
this population, and also the familial aggregation of refractive errors, lens opacity, ocular
hypertension, and color blindness within the study sample.
Methods Design: Through a population-based, cross-sectional study, a total of 5300 Tehran
citizens will be selected from 160 clusters using a stratified cluster random sampling strategy. The
eligible people will be enumerated through a door-to-door household survey in the selected
clusters and will be invited. All participants will be transferred to a clinic for measurements of
uncorrected, best corrected and presenting visual acuity; manifest, subjective and cycloplegic
refraction; color vision test; Goldmann applanation tonometry; examination of the external eye,
anterior segment, media, and fundus; and an interview about demographic characteristics and
history of eye diseases, eye trauma, diabetes mellitus, high blood pressure, and ophthalmologic
cares. The study design and eye examination protocol are described.
Conclusion: We expect that findings from the TES will show the status of visual problems and
their causes in the community. This study can highlight the people who should be targeted by visual
impairment prevention programs.
Background
Visual impairment is a global public health problem.
Worldwide, an estimated 45 million people are blind, and
an additional 135 million have severe visual impairment.
[1,2] The prevalence of blindness in developing countries
is 10–40 times higher than in developed countries, and
close to three quarters of the world's blindness is either
curable or preventable. The majority of blind people on
earth reside in the developing nations of Africa, Asia, and
Latin America. [3] There are several studies on the
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Eastern Mediterranean countries. [3,7,31–33] Popula-
tion-based data on frequency and causes of visual impair-
ment are useful for identifying needs for treatment and
rehabilitation services, planning and implementing
blindness prevention programs, and determining research
priorities for different populations.
There are very few published studies concerning this issue
in the Iranian population. [36] Iran's National Health Sur-
vey provides data on visual impairment in this country.
[37] These data, based on self-reporting, have some limi-
tations. The goal of the present project is to describe the
prevalence and causes of visual impairment in the popu-
lation of Tehran city.
Specific Objectives
To determine the prevalence of visual impairment (low
vision and blindness) in Tehran population.
To evaluate the determinants of visual impairment within
the study sample.
To determine the prevalence of refractive errors, lens opac-
ity, ocular hypertension and color blindness in Tehran
population.
To describe the familial aggregation of refractive errors,
lens opacity, ocular hypertension, and color blindness
within the study sample.
Methods/Design
The Tehran Eye Study has been designed as a cross-sec-
tional survey in the population of the urban area of
Tehran city.
Population and sampling strategy
Tehran population
The Tehran region, which is a part of Tehran province,
includes the cities of Tehran, Karaj, Savejbolagh, Shahryar,
Shemiran, Rey, Eslamshahr and Varamin. On account of
common borders and due to close economic and social
links, this area is called "the Tehran region". These various
cities became a collective entity in 1966, and their links
have become more intensified since 1976. The 1996 cen-
sus recorded Tehran region's population as 9.4 million,
6.8 million of which belonged to Tehran city alone.
The sampling frame is considered the population of the
urban area of Tehran city. Table 1 shows the distribution
of Tehran population and families in the 22 municipal
districts according to the 1996 census. It is estimated that
the present total population in this area is nearly 7.5 mil-
lion, but there is no evidence suggesting any change in the
distribution. So we will distribute our clusters on the basis
of the population size of each district in 1996.
Number of Households in Tehran City
Census 1996 statistics showed that there were 1,660,219
households in Tehran city. Table 1 presents the number of
households within each district of Tehran city. House-
holds averaged 4.3 people in 1996.
Sample Size
For sample size calculation, the objective we have consid-
ered is to estimate the prevalence of variables with propor-
tions as little as 0.02 (P). On this assumption, for a 95%
confidence interval (Z1-α/2 = 1.96) and precision of 0.005
(d), the sample size is calculated as follows:
Considering a design effect of 1.5 and a response rate of
85%, total sample size is calculated by the following
equation:
n = 3010 × 1.5 × 1/0.85 ≈ 5300.
Sampling Plan
This study follows a stratified cluster sampling strategy
with proportional allocation within strata. The target pop-
ulation is all urban non-institutionalized citizens, of all
ages, who reside in Tehran city in the year 2002. The strat-
ification of the sample according to the 22 municipal dis-
tricts of Tehran city is incorporated in the sampling
process. Proportional to the number of households in the
22 districts (table 1), the appropriate number of clusters is
assigned to each district (table 2). A total of 160 clusters
are randomly selected based on blocks enumeration of
the national census of 1996 by the Iranian Statistics
Center. The decision about the number of clusters is based
on total sample size; mean household members; and
logistical facilities for subject enumeration, transport, and
examination. For each cluster, a team of 2 interviewers
(one male and one female) approaches the index house-
hold, which is specified through the aforementioned ran-
dom selection of clusters, and continues the enumeration
in 10 neighbor households in a systematic manner by pro-
ceeding round in a clock-wise direction. If more than one
household inhabits a building, one will be randomly
selected. They introduce themselves by presenting their
identification cards. Then they describe the project to the
present members of the households. At the end, all
household members (people who have lived together in a
housing unit for 6 months or more over the past year) are
invited for a complete eye examination at Noor Vision
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hold members are informed that they will be transported
to the clinic by the project staff. The enumeration teams
approach clusters on Mondays and Tuesdays, and partici-
pants are examined on Thursdays and Fridays (formal
weekend in Iran). Nine clusters are covered, and nearly
240 participants are visited weekly.
Non-response
Enumerated subjects who do not attend the examination
process following the initial invitation will be contacted
twice in subsequent weeks. Those who fail to appear even
after the third invitation will be considered non-respond-
ent.
Examination Protocol
The examination protocol includes lensometry; uncor-
rected, best corrected and presenting visual acuity meas-
urements; manifest, subjective and cycloplegic refraction;
color vision test; Goldmann applanation tonometry;
examination of the external eye, anterior segment, media,
and fundus; and an interview about demographic charac-
teristics, history of eye diseases, eye trauma, diabetes mel-
litus, high blood pressure, and ophthalmologic cares
(Figure 1).
Visual Acuity and Refraction
An optometrist determines the visual acuity by using a
NIDEK chart projector (CP – 670 20/10–20/400; Nidek
Co, Gamagori, Japan) with tumbling E letters at a distance
of 4 meters. Best spectacle corrected and uncorrected vis-
ual acuity tests are performed separately for each eye (one
eye at a time). Presenting visual acuity is measured with
the participant's habitual distance correction. Lensometry
is performed by an optometrist for those who use glasses.
Visual acuity is recorded as the smallest line in which the
patient can read the four letters correctly. If the person is
unable to read the largest E letters in the chart (20/400 E
letters) at 4 meters, then finger counting is done at 1
meter. The examiner stands one meter in front of the par-
ticipant and asks if the participant can see his/her hand.
The examiner slowly waves his/her hand and asks the par-
ticipant if he/she can see what the hand is doing. If the
participant is able to see the examiners hand moving,
"hand motion" is recorded on the exam form. If the par-
ticipant cannot see the examiner's hand, a penlight is held
in front of the participant's eye and he/she is asked if he/
she can tell when the light is on. If the participant can cor-
rectly identify when the light is on, "light perception" is
recorded on the exam form. If the participant is unable to
see the light, "no light perception" is recorded. Care will
Table 1: Distribution of Tehran population in the 22 municipal districts (1996 census).
Family Population
District Number Percent Number Percent
1 66,142 3.98 249,676 3.69
2 120,333 7.25 458,089 6.78
3 71,746 4.32 259,019 3.83
4 155,214 9.35 663,166 9.81
5 105,186 9.34 427,995 6.33
6 60,063 3.62 220,331 3.26
7 81,657 4.92 300,212 4.44
8 89,103 5.37 336,474 4.98
9 42,847 2.58 173,482 2.57
10 75,064 4.52 282,308 4.18
11 59,065 3.56 225,840 3.34
12 48,579 2.92 189,625 2.81
13 61,062 3.68 245,142 3.63
14 98,140 5.91 394,611 5.84
15 142,236 8.57 622,517 9.21
16 71,269 4.29 298,410 4.42
17 66,711 4.02 287,367 4.25
18 64,241 3.87 296,243 4.38
19 47,381 2.85 227,389 3.36
20 80,835 4.87 356,079 5.27
21 40,746 2.45 188,890 2.79
22 12,599 0.76 56,020 0.83
Total 1,660,219 100 6,758,845 100Page 3 of 8
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Examination process flowchart. UCVA = uncorrected visual acuity; BCVA = best-corrected visual acuity; VA = visual acuity; 
IOP = intraocular pressure.
Table 2: Number of clusters in the 22 municipal districts of Tehran.
District Number of clusters District Number of clusters
1 6 12 5
2 12 13 6
3 7 14 9
4 15 15 14
5 10 16 7
6 6 17 6
7 8 18 6
8 9 19 4
9 4 20 8
10 7 21 4
11 6 22 1Page 4 of 8
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covered with the palm or cloth and not pressed.
Refraction is done on all participants of five years of age
and over using a Topcon automated refractometer (Top-
con KR 8000, Topcon Corporation, Tokyo, Japan) by an
optometrist. The optometrists act according to the
instruction manual of Topcon KR 8000. Results from
autorefraction are used as a starting point for a full subjec-
tive and manifest refraction. If autorefraction is not possi-
ble (especially due to a media opacity) manual manifest
and subjective refraction is attempted. On the judgment
of an ophthalmologist, if there is no contraindication,
cycloplegic refraction is done. In this case, cyclopentolate
1%, 2 drops are instilled 30 and 25 minutes before refrac-
tion. The participants are warned about the symptoms of
cyclopentolate.
Color vision test
Using Farnsworth D-15 test, an optometrist tests color
vision in all participants of at least 7 years of age. The
Farnsworth D-15 test consists of 15 colored papers
selected from the hue circle mounted in plastic caps. The
participant is given the tray and allowed 2 minutes to
arrange the hue in serial order according to their colors.
Eye Examination
Eyelid, globe, and anterior segment examination is per-
formed at the first ophthalmologic visit. Presence of globe
is recorded. In order to assess defective eyelid closure, the
participant is asked to close the eyes. In cases of lagoph-
thalmos, ectropion, loss of lid margin, etc, the lid may not
come into apposition. Then the condition is specified.
For all participants of five years of age and over, a slitlamp
examination is done (Topcon slitlamp, Topcon Corpora-
tion, Tokyo, Japan). The participant is seated comfortably
at the slitlamp with his/her chin firmly on the chin rest
and forehead against the headrest. The examiner then
examines the anterior segment of each eye adjusting the
beam width, magnification, and beam angle to achieve
the best view of all the structures in the anterior segment.
In viewing the cornea, the presence of arcus and the
amount of involvement, any corneal scars, lesions, or
abnormalities are recorded. The sclera, conjunctiva, and
iris are all inspected for the presence of any lesions and
abnormalities. The presence of pinguecula and pyterigia
are recorded. A pyterigium is distinguished from a
pingueculum if it crosses the limbus.
Iris color determination
Iris color is determined by viewing the participant's iris
with the pupil undilated using a penlight. The color is
compared to a color standards developed on the basis of
the standards used in Beaver Dam Eye Study. Although
the choices on the form are "gray or blue", "yellow or
green", "light brown", "medium brown" and "dark", the
amount of pigment in the iris is taken into account rather
than the actual color. When an iris has more than one
color, the grade is assigned based on the color which is
50% or more.
Intraocular pressure
The intraocular pressure (IOP) is measured using a Gold-
mann applanation tonometer. A drop of tetracain is
instilled in each eye of the participant and tear is stained
with fluorescein. The tonometer is swung into place on
the slitlamp, the blue filter put into place, and the beam
width opened to its fullest height. The beam angle should
be about 45–60 degrees to the side of the tonometer and
should illuminate the end of the prism head. The exam-
iner should be aware of possible contact of the tonometer
with the lids, lashes, or beard; all of which may cause a
"high" reading. If IOP is >30 mmHg, it is rechecked after
dilation. If IOP is >40 mmHg, the ophthalmologist pre-
scribes appropriate treatment for the participant and
informs him / her about the disease. Time of IOP meas-
urement is recorded. The participant is asked whether he
or she is currently taking medication for glaucoma. If the
answer is affirmative, the drug is recorded.
Angle assessment
The angle of the anterior chamber is evaluated to deter-
mine the risk of occlusion upon dilation. The examiner
assesses the angle by viewing it nasally and temporally
with a narrow beam directed at an angle of about 45
degrees. If the ophthalmologist feels the chamber angle to
be occludable, dilating drops are not administered. When
the examiner is in doubt, another examiner will be con-
sulted. If the chamber does not appear occludable, dilat-
ing drops are administered following the intraocular
pressure test.
Clinical lens opacities grading
The ophthalmologist grades cortical and posterior sub-
capsular opacities, nuclear opalescence and color by vis-
ual comparison with a standard photograph (the Lens
Opacities Classification System III, LOCS III) [38]
through the biomicroscopic ophthalmic exam by a Top-
con slitlamp (Topcon Corporation, Tokyo, Japan).
Direct and Indirect ophthalmoscopy
All participants of five years of age and over undergo a ret-
inal exam first using direct ophthalmoscopy followed by
indirect ophthalmoscopy. The retina is examined
systematically to ensure that no lesions are passed over.
The examiner inspects the optic disc assessing disc size,
color, vascularity, and degree of cupping. The retinal exam
proceeds systematically, not overlooking any lesions or
abnormalities such as congenital anomalies, signs of earlyPage 5 of 8
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retinopathy, Drusen, retinal detachment, and different
types of diabetic retinopathy, which are recorded on the
exam form if present.
Definitions
Visual impairment
The 10th edition of the International Classification of Dis-
eases (ICD10) defines visual impairment as a visual acuity
of less than 6/18 (20/60, 0.3) in the better eye with the
best correction. [39] Visual impairment is categorized to
blindness and low vision. Blindness is a visual acuity of
less than 3/60 (20/400, 0.05) in the better eye with the
best correction. Low vision is defined as a best corrected
visual acuity of less than 6/18 (20/60, 0.3) but not less
than 3/60 (20/400, 0.05) in the better eye. The cause of
visual impairment is identified by an ophthalmologist.
Using the best judgment, the ophthalmologist will deter-
mine one cause for each eye thought to be the principal
cause in either eye. When multiple disorders are present,
the ophthalmologist attempts to identify the disorder
causing the greatest limitation of vision. If there are any
other contributory causes, the ophthalmologist specifies
that as a second cause. In cases with different causes of vis-
ual reduction in the patient's two eyes, the diagnosis in
the less affected eye is used. Cataract is considered the
main cause of severe low vision if the fundus is obscured
by lens changes, or if no evident fundus abnormalities are
observed in eyes with significant cataract. Regarding the
results of exams, the ophthalmologist specifies whether
the participant needs any action and specifies the type of
needed action.
Observers Training and quality assurance
All observers (including enumerators, optometrists and
ophthalmologists) take part in a comprehensive training
course, which has been developed for conducting the pro-
tocol. The course includes a full spectrum of education to
ensure that all investigators have a broad based knowl-
edge of the study process, study purposes, data forms, and
technical skills needed to conduct the protocol in a scien-
tifically sound manner. All staff must complete the train-
ing course prior to getting involved in the study. The
program director and manager directly supervise the staff
training process.
All observers receive regular quality control visits from the
project manager who checks their performance. In addi-
tion, the data are reviewed periodically, and feedback is
given to the observers weekly.
Pilot and reliability study
In order to assess the protocol, sampling process, partici-
pants' transport, data forms, equipment, and interob-
server agreement, a pilot study is done one month before
starting the study. The pilot study is done on 3 clusters in
different districts outside those selected for the main
study. To determine the reliability coefficient for visual
acuity and refraction, the procedures are repeated twice by
two series of observers. The agreement rates are calculated.
Humanity and ethics
The study is approved by the Research and Ethics Com-
mittee of Noor Vision Correction Center and Ethics Com-
mittee of the National Research Center for Medical
Sciences. All subjects included in this study will be
informed about the project and the procedures in their
native language before being enrolled. They will be
informed that their participation is entirely voluntary and
they may decide to withdraw from the study at any time.
The participants' agreement for examination will be
obtained verbally. The confidentiality of all study partici-
pants will be protected in accordance with a good epide-
miological practice.
Data handling and statistical analysis
Data entry
During the enumeration process, as data on each house-
hold is completed, a supervisor will do a quick check to
see that all data is collected properly. Similarly, during the
eye examination at the clinic, as each person completes
the eye exam, the supervisor checks all data forms to
ensure that all relevant data has been collected. Missing
data and mistakes are rectified after consulting the con-
cerned person.
Data editing
During data entry, the forms will be checked for complete-
ness and consistency by the data entry software. If the
forms are not filled in completely, the concerned person
will be consulted to fill in the missing data or clarify an
inconsistent data. All changes and coding will be made in
ink by crossing out the original data and recording the
new data beside it. It will be signed and dated by the per-
son making the changes. Overwriting will be avoided.
Statistical analysis
In calculating standard errors and the 95% confidence
interval for categorical and continuous variables, the clus-
ter sampling design is taken into account and adjusted for.
[40] In addition to descriptive analyses, odds ratios are
calculated with multivariate logistic regression in order to
control potential confounding variables, and account for
cluster design effects.
A familial association of qualitative variables may be
assessed by an odds ratio (OR) [41] that, for any pair j and
k of individuals in a family, is defined as the odds of per-
son j having an outcome given person k has the same out-
come divided by the odds of person j having the outcomePage 6 of 8
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ing variables, we will use the second-order generalized
estimating equations (GEE2) approach to logistic regres-
sion that simultaneously models the risk of a person hav-
ing myopia and the familial associations. [41,42] In order
to assess the degree of familial association for quantitative
variables (e.g., spherical equivalent and cylindrical
power) we computed Pearson correlation coefficients for
all possible pairs of siblings. All analyses will be done
using STATA statistical software, version 6.0 (STATA Cor-
poration, TX).
Discussion
This study protocol describes the study design and eye
examination of a cross-sectional population-based study
in Tehran population. We expect that findings from the
TES will show the status of visual problems and their
causes in the community. This study will highlight the
people who should be targeted by intervention programs
for prevention of visual impairment.
List of abbreviations used
VA = visual acuity
UCVA = uncorrected visual acuity
BCVA = best corrected visual acuity
IOP = intraocular pressure
ICD10 = The International Classification of Diseases, 10th
edition
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